Howard Sauls

Howard Sauls has amassed extensive work experience in the field of scientific research and development. Howard'scareer began at the University of North Carolina at Chapel Hill as a Technician II before moving on to RTI International as a Biologist III. Howard then spent several years at GSK, progressing from Scientist to Principal Scientist. Following this, they held roles at Intarcia Therapeutics, Inc. and Ribometrix Inc. before their current position as a Principal Scientist at Aktis Oncology. Throughout their career, Howard has demonstrated expertise in various scientific roles, culminating in their current senior position.

Howard Sauls earned a Bachelor of Science degree in Biology from the University of North Carolina at Chapel Hill from 1981 to 1985.